Clinical trial
Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
NCT03383419 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
- Lead sponsor
- Baylor Research Institute
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- March 20, 2018
- Completion date
- December 30, 2026
- Enrollment
- 15 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.